Daikaffil Chemicals India Ltd
₹ 218
1.99%
13 Dec
- close price
About
Established in 1992, Daikaffil Chemicals Pvt. Ltd. is engaged in manufacturing of organic chemicals and intermediaries and trading of chemicals.
Key Points
- Market Cap ₹ 131 Cr.
- Current Price ₹ 218
- High / Low ₹ 261 / 72.0
- Stock P/E
- Book Value ₹ 16.1
- Dividend Yield 0.00 %
- ROCE -17.3 %
- ROE -17.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Promoter holding has increased by 0.95% over last quarter.
Cons
- Stock is trading at 13.6 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -12.0% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Dyes And Pigments
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.93 | 33.28 | 34.35 | 27.41 | 26.44 | 22.82 | 16.84 | 15.72 | 11.40 | 8.16 | 0.64 | -0.00 | 0.00 | |
| 27.98 | 30.31 | 31.36 | 24.24 | 21.77 | 19.53 | 15.04 | 13.88 | 11.23 | 10.20 | 2.58 | 2.25 | 2.90 | |
| Operating Profit | 1.95 | 2.97 | 2.99 | 3.17 | 4.67 | 3.29 | 1.80 | 1.84 | 0.17 | -2.04 | -1.94 | -2.25 | -2.90 |
| OPM % | 6.52% | 8.92% | 8.70% | 11.57% | 17.66% | 14.42% | 10.69% | 11.70% | 1.49% | -25.00% | -303.12% | ||
| 0.45 | 0.29 | -0.16 | 0.55 | 0.55 | 0.85 | 0.42 | 0.85 | 0.55 | 0.47 | 0.41 | 0.71 | 0.50 | |
| Interest | 0.35 | 0.36 | 0.26 | 0.14 | 0.07 | 0.05 | 0.03 | 0.07 | 0.05 | 0.03 | -0.00 | -0.00 | 0.00 |
| Depreciation | 0.56 | 0.61 | 0.42 | 0.40 | 1.48 | 0.97 | 0.96 | 1.12 | 1.12 | 1.13 | 0.54 | 0.35 | 0.03 |
| Profit before tax | 1.49 | 2.29 | 2.15 | 3.18 | 3.67 | 3.12 | 1.23 | 1.50 | -0.45 | -2.73 | -2.07 | -1.89 | -2.43 |
| Tax % | 34.23% | 37.55% | 27.91% | 33.96% | 33.51% | 23.40% | 29.27% | 28.00% | -11.11% | -8.42% | 2.90% | 0.53% | |
| 0.98 | 1.44 | 1.55 | 2.10 | 2.44 | 2.40 | 0.86 | 1.08 | -0.41 | -2.50 | -2.13 | -1.90 | -2.11 | |
| EPS in Rs | 1.63 | 2.40 | 2.58 | 3.50 | 4.07 | 4.00 | 1.43 | 1.80 | -0.68 | -4.17 | -3.55 | -3.17 | -3.52 |
| Dividend Payout % | 30.61% | 33.33% | 30.97% | 28.57% | 41.80% | 30.00% | -0.00% | 38.89% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 64% |
| 3 Years: | 88% |
| 1 Year: | 179% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -6% |
| 3 Years: | -12% |
| Last Year: | -17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
| Reserves | 3.56 | 4.43 | 5.22 | 6.60 | 18.38 | 19.54 | 19.46 | 19.96 | 19.58 | 18.52 | 6.44 | 4.54 | 3.65 |
| 2.85 | 2.37 | 1.89 | 0.71 | -0.00 | -0.00 | -0.00 | 0.71 | 0.56 | 0.37 | -0.00 | -0.00 | -0.00 | |
| 6.18 | 9.38 | 6.83 | 5.56 | 3.35 | 4.72 | 2.64 | 3.54 | 2.36 | 1.81 | 0.63 | 1.61 | 1.82 | |
| Total Liabilities | 18.59 | 22.18 | 19.94 | 18.87 | 27.73 | 30.26 | 28.10 | 30.21 | 28.50 | 26.70 | 13.07 | 12.15 | 11.47 |
| 5.53 | 5.51 | 5.37 | 5.34 | 15.14 | 14.69 | 14.16 | 14.01 | 12.98 | 13.92 | 2.01 | 1.63 | 1.47 | |
| CWIP | 0.18 | -0.00 | -0.00 | 0.04 | 0.09 | 0.01 | 0.02 | 0.04 | 0.03 | 0.05 | 0.05 | 0.05 | 0.15 |
| Investments | 0.08 | 0.06 | 0.10 | 0.25 | 0.28 | 2.27 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.25 |
| 12.80 | 16.61 | 14.47 | 13.24 | 12.22 | 13.29 | 13.73 | 15.97 | 15.30 | 12.54 | 10.82 | 10.28 | 9.60 | |
| Total Assets | 18.59 | 22.18 | 19.94 | 18.87 | 27.73 | 30.26 | 28.10 | 30.21 | 28.50 | 26.70 | 13.07 | 12.15 | 11.47 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.87 | 1.45 | 1.73 | 0.72 | 5.04 | 2.65 | 2.28 | 3.39 | 0.21 | -0.86 | -8.13 | 5.92 | |
| -0.48 | -0.41 | -0.51 | -0.47 | -0.93 | -2.70 | 1.86 | 0.14 | 0.21 | 0.20 | 0.57 | 0.60 | |
| -0.57 | -0.53 | -0.59 | -0.58 | -0.72 | -1.23 | -0.87 | -0.69 | -0.16 | -0.12 | -0.00 | -0.00 | |
| Net Cash Flow | -0.18 | 0.51 | 0.62 | -0.32 | 3.39 | -1.27 | 3.27 | 2.84 | 0.26 | -0.78 | -7.56 | 6.52 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 80.85 | 93.22 | 72.36 | 93.48 | 40.03 | 74.22 | 60.26 | 45.04 | 28.82 | 6.26 | -0.00 | |
| Inventory Days | 81.75 | 93.77 | 70.49 | 81.93 | 82.17 | 84.50 | 122.29 | 133.94 | 154.33 | 124.16 | 1,116.90 | |
| Days Payable | 90.13 | 132.45 | 85.28 | 69.49 | 34.20 | 80.69 | 39.27 | 80.53 | 59.90 | 7.49 | 21.90 | |
| Cash Conversion Cycle | 72.47 | 54.55 | 57.57 | 105.91 | 88.00 | 78.03 | 143.28 | 98.46 | 123.24 | 122.94 | 1,095.00 | |
| Working Capital Days | 75.61 | 71.84 | 67.79 | 93.08 | 76.89 | 93.25 | 113.14 | 76.85 | 105.66 | 115.40 | 4,956.02 | |
| ROCE % | 15.49% | 21.18% | 18.76% | 25.06% | 19.85% | 12.70% | 4.94% | 5.99% | -1.51% | -10.58% | -11.09% | -17.32% |
Documents
Announcements
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
1d - Acquired 13,624 equity shares of Daikaffil Chemicals.
-
Disclosures Under Reg. 29(2) Of SEBI (SAST) Regulations, 2011
1d - Acquisition of 13,624 equity shares of Daikaffil Chemicals.
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 10 Dec
-
Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011
10 Dec - Acquired 6,000 equity shares of Daikaffil Chemicals.
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
9 Dec - Acquired 20,000 equity shares of Daikaffil Chemicals.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:
Company's main products are various types of:
a) Optical Brighteners:[1]
Also known as fluorescent whitening agents, these are used to make paper, textiles, plastics, fibers, coatings, inks, detergents, etc.
b) Stilbene Derivatives:[2]
Company provides products like Paranitro Toluene Ortho -Sulfonic Acid, Diamino Stilbene 2.2' -Disulfonic Acid, etc. in wet and dry form.
c) Dye Intermediates:[3]
Company has 12 products under this category which are used for manufacture of direct dyes, acid dyes, pigments, dyestuffs, etc.
d) Naphthol:[4]
It is an organic compound used to manufacture organic Pigments/Master batch. Pigments are used for colouring paint, ink, plastic, fabric, cosmetics, foods and other materials.